IRIS
AVAGLIANO, CARMEN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.550
NA - Nord America 1.442
EU - Europa 1.327
SA - Sud America 198
AF - Africa 42
OC - Oceania 4
Totale 4.563
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.382
SG - Singapore 680
RU - Federazione Russa 575
IT - Italia 343
VN - Vietnam 326
CN - Cina 295
BR - Brasile 158
HK - Hong Kong 103
FR - Francia 73
DE - Germania 67
NL - Olanda 60
CA - Canada 44
FI - Finlandia 43
GB - Regno Unito 40
IE - Irlanda 39
IN - India 26
JP - Giappone 18
AR - Argentina 14
ZA - Sudafrica 14
ES - Italia 13
UA - Ucraina 13
BD - Bangladesh 12
TH - Thailandia 12
KR - Corea 11
CI - Costa d'Avorio 9
MX - Messico 9
PH - Filippine 9
TR - Turchia 9
AT - Austria 8
PL - Polonia 8
SE - Svezia 8
BG - Bulgaria 7
EC - Ecuador 7
CZ - Repubblica Ceca 6
IQ - Iraq 6
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
LT - Lituania 5
CL - Cile 4
ID - Indonesia 4
SK - Slovacchia (Repubblica Slovacca) 4
VE - Venezuela 4
AU - Australia 3
BE - Belgio 3
EG - Egitto 3
KZ - Kazakistan 3
PS - Palestinian Territory 3
BO - Bolivia 2
EE - Estonia 2
ET - Etiopia 2
GA - Gabon 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
MA - Marocco 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PY - Paraguay 2
RO - Romania 2
UZ - Uzbekistan 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GH - Ghana 1
GM - Gambi 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
PG - Papua Nuova Guinea 1
RS - Serbia 1
SA - Arabia Saudita 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
ZM - Zambia 1
Totale 4.563
Salva come PNG Salva come JPEG
Città #
Singapore 349
San Jose 185
Chandler 160
Moscow 147
Ashburn 136
Beijing 105
Hong Kong 99
Ho Chi Minh City 93
Naples 92
Hanoi 60
Amsterdam 51
Santa Clara 47
Los Angeles 43
Napoli 42
Dallas 41
Hefei 33
Millbury 32
Lauterbourg 31
Dearborn 29
Dong Ket 26
Des Moines 23
Boston 21
Council Bluffs 19
Da Nang 19
Princeton 19
Munich 18
Frankfurt am Main 16
São Paulo 16
Turku 16
Chicago 15
Haiphong 15
New York 15
Tokyo 15
Ottawa 13
Buffalo 12
Orem 12
London 11
Redondo Beach 11
The Dalles 11
Falkenstein 10
Lawrence 10
Milan 10
Montreal 10
Atlanta 9
Houston 9
Nanjing 9
Dublin 8
Nanchang 8
Toronto 8
Wilmington 8
Brooklyn 7
Cagliari 7
Rome 7
Seattle 7
Seoul 7
Sofia 7
Stockholm 7
Changsha 6
Denver 6
Helsinki 6
Phoenix 6
Pune 6
Shenyang 6
Vienna 6
Bangkok 5
Brno 5
Jacksonville 5
Thái Nguyên 5
Afragola 4
Bacoli 4
Belo Horizonte 4
Curitiba 4
Hebei 4
Istanbul 4
Lappeenranta 4
Manchester 4
Menlo Park 4
Ninh Bình 4
Norwalk 4
Poplar 4
Redwood City 4
San Vitaliano 4
Shanghai 4
Warsaw 4
Baghdad 3
Biên Hòa 3
Brasília 3
Córdoba 3
Frankfurt Am Main 3
Guangzhou 3
Guarulhos 3
Jinan 3
Johannesburg 3
Memphis 3
Mexico City 3
Mumbai 3
Newark 3
Nuremberg 3
Parma 3
Piovene Rocchette 3
Totale 2.420
Salva come PNG Salva come JPEG
Nome #
Pharmacokinetic characteristics and pharmacological profile of polyethylenglicole derivatives of palmitoylethanolamide (PEA) 190
Analgesic properties of N-(1-carbomyl 2-phenyl-ethyl)butyramide a new synthetic butyrate pro-drug in a model of acute and visceral pain 188
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity 188
Gut-brain axis: Role of lipids in the regulation of inflammation, pain and CNS diseases 186
Phenylalanine Butyramide Is a New Cosmetic Ingredient with Soothing and Anti-Reddening Potential 180
Characterization of New TRPM8 Modulators in Pain Perception 169
Improvement of Topical Palmitoylethanolamide Anti-Inflammatory Activity by Pegylated Prodrugs 159
Fatty acid acyl ethanolamines and PPAR-alpha in neurodegenerative and neurological diseases. Cellular models of neurodegeneration: preliminary data 152
Peroxisome proliferator-activated receptor (PPAR)-alpha activation produces antidepressant-like effects in mice 150
Oral sodium butyrate supplementation ameliorates paclitaxel-induced behavioral and intestinal dysfunction 145
Central administration of oxytocin reduces hyperalgesia in mice: Implication for cannabinoid and opioid systems. 145
Role of sodium butyrate and of its new prodrug N-(1-carbamoyl-2-phenyl-ethyl) butyramide (FBA) in gastrointestinal transit, castor oil-induced diarrhoea, and croton oil-induced intestinal inflammation 143
Potential Clinical Applications of the Postbiotic Butyrate in Human Skin Diseases 142
Uncovering the role of the lipid receptor PPAR-alpha on higher brain functions 140
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy. 133
Phaseolus vulgaris L. Extract: Alpha-amylase inhibition against metabolic syndrome in mice 133
Ketogal: A Derivative Ketorolac Molecule with Minor Ulcerogenic and Renal Toxicity 132
Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy 130
Palmitoylethanolamide Protects Against the Amyloid-β25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease. 130
Sodium butyrate and its synthetic amide derivative modulate nociceptive behaviors in mice 125
Nutraceuticals: An integrative approach to starve Parkinson’s disease 125
Peroxisome proliferator-activated receptor alpha plays a crucial role in behavioral repetition and cognitive flexibility in mice 123
Galactosyl prodrug of palmitoylethanolamide: Synthesis, stability, cell permeation and cytoprotective activity 120
Antinociceptive effect of two novel transient receptor potential melastatin 8 antagonists in acute and chronic pain models in rat 119
Effects of Chronic Oral Probiotic Treatment in Paclitaxel-Induced Neuropathic Pain 117
Biological Profile of Two Gentiana lutea L. Metabolites Using Computational Approaches and In Vitro Tests 113
Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl-2′-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 112
Effects of a probiotic suspension Symprove™ on a rat early-stage Parkinson's disease model 106
The Beneficial Effects of Ultramicronized Palmitoylethanolamide in the Management of Neuropathic Pain and Associated Mood Disorders Induced by Paclitaxel in Mice 106
The Protective Role of Butyrate against Obesity and Obesity-Related Diseases 101
Phaseolus vulgaris extract ameliorates high-fat diet-induced colonic barrier dysfunction and inflammation in mice by regulating peroxisome proliferator-activated receptor expression and butyrate levels 98
Response to comment by Juan Segura-Aguilar: New preclinical model are required to discover neuroprotective compound in Parkinson's disease 94
Modulation of Pain Sensitivity by Chronic Consumption of Highly Palatable Food Followed by Abstinence: Emerging Role of Fatty Acid Amide Hydrolase 94
Dual-Hit Model of Parkinson's Disease: Impact of Dysbiosis on 6-Hydroxydopamine-Insulted Mice-Neuroprotective and Anti-Inflammatory Effects of Butyrate. [*Avagliano C. and Coretti L. co-first authors] 89
Palmitoylethanolamide protects mice against 6-OHDA-induced neurotoxicity and endoplasmic reticulum stress: In vivo and in vitro evidence 85
Expression of VEGF-A/VEGFR-2 pathway in feline oral squamous cell carcinoma in vitro and anti-tumour effect of Bevacizumab in a xenograft model 2
Totale 4.664
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.880
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.880
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 0 0 0 0 0 9 33
2021/2022261 2 1 2 22 25 3 7 8 33 23 59 76
2022/2023414 30 16 18 42 52 43 6 56 56 58 31 6
2023/2024207 11 30 33 15 10 18 14 30 1 8 21 16
2024/20251.161 62 37 4 21 27 50 120 97 65 104 472 102
2025/20262.166 224 121 274 203 437 85 211 108 270 174 59 0
Totale 4.664